QuiVad
My list

Home / Japan / Chiome Bioscience Inc.

Chiome Bioscience Inc.

Short position disclosed on October 5, 2026.

Follow

Evolution of the disclosed total

0%2%4%6%
Aug 16Aug 29Sep 11Sep 24Oct 7
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Barclays Capital Securities Ltd1.64%+1.04 ptOctober 2, 2026
モルガン・スタンレーmufg証券株式会社1.06%newOctober 5, 2026

Follow by RSS

Get the moves on Chiome Bioscience Inc. by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

52 disclosures on record for this share.
DateFund% of capitalEnd of publication
October 5, 2026モルガン・スタンレーmufg証券株式会社1.06%still open
October 2, 2026Barclays Capital Securities Ltd1.64%still open
October 2, 2026モルガン・スタンレーmufg証券株式会社1.23%
October 1, 2026Barclays Capital Securities Ltd1.44%
September 29, 2026モルガン・スタンレーmufg証券株式会社1.45%
September 29, 2026Arrowstreet Capital, Limited Partnership0.58%
September 28, 2026モルガン・スタンレーmufg証券株式会社1.27%
September 28, 2026Arrowstreet Capital, Limited Partnership0.98%
September 25, 2026Barclays Capital Securities Ltd1.19%
September 25, 2026モルガン・スタンレーmufg証券株式会社1.15%
September 24, 2026Arrowstreet Capital, Limited Partnership0.65%
September 24, 2026Nomura International plc0.43%
September 18, 2026モルガン・スタンレーmufg証券株式会社1.08%
September 18, 2026Nomura International plc0.53%
September 17, 2026モルガン・スタンレーmufg証券株式会社1.39%
September 17, 2026Barclays Capital Securities Ltd1.21%
September 17, 2026Nomura International plc0.78%
September 16, 2026モルガン・スタンレーmufg証券株式会社1.40%
September 16, 2026Barclays Capital Securities Ltd1.18%
September 15, 2026モルガン・スタンレーmufg証券株式会社1.58%
September 15, 2026Barclays Capital Securities Ltd1.20%
September 14, 2026モルガン・スタンレーmufg証券株式会社1.72%
September 14, 2026Barclays Capital Securities Ltd1.17%
September 11, 2026モルガン・スタンレーmufg証券株式会社1.81%
September 11, 2026Barclays Capital Securities Ltd0.97%
September 10, 2026モルガン・スタンレーmufg証券株式会社2.30%
September 10, 2026Nomura International plc0.98%
September 10, 2026Barclays Capital Securities Ltd0.64%
September 9, 2026モルガン・スタンレーmufg証券株式会社2.42%
September 9, 2026Barclays Capital Securities Ltd0.34%
September 8, 2026モルガン・スタンレーmufg証券株式会社2.27%
September 8, 2026Nomura International plc1.19%
September 8, 2026Barclays Capital Securities Ltd0.75%
September 7, 2026Nomura International plc1.27%
September 7, 2026モルガン・スタンレーmufg証券株式会社1.19%
September 7, 2026Barclays Capital Securities Ltd0.84%
September 4, 2026Nomura International plc2.12%
September 4, 2026モルガン・スタンレーmufg証券株式会社0.87%
September 4, 2026Barclays Capital Securities Ltd0.67%
August 28, 2026Nomura International plc0.54%
August 26, 2026モルガン・スタンレーmufg証券株式会社0.65%
August 24, 2026モルガン・スタンレーmufg証券株式会社0.74%
August 20, 2026Nomura International plc0.37%
August 19, 2026Nomura International plc0.53%
August 18, 2026みずほ証券株式会社0.00%
August 14, 2026モルガン・スタンレーmufg証券株式会社0.82%
August 12, 2026Nomura International plc0.46%
August 10, 2026モルガン・スタンレーmufg証券株式会社0.98%
August 7, 2026Nomura International plc0.61%
August 7, 2026Barclays Capital Securities Ltd0.48%

Download 52 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Japan

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Chiome Bioscience Inc., source JPX, data as at October 5, 2026, https://www.quivad.com/action/chiome-bioscience-inc